Jeffrey Oram - 15 Mar 2022 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role: Director
Signature: /s/ Jeffrey Oram
Issuer symbol: ALZN
Transactions as of: 15 Mar 2022
Transactions value $: $0
Form type: 4
Filing time: 16 Mar 2022, 16:30:12 UTC
Previous filing: 18 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALZN	Common Stock	Options Exercise	$0	+50K	+100%	$0.00	100K	15 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALZN	Restricted Stock Grant	Options Exercise	$0	-50K	-100%	$0.00^*	0	15 Mar 2022	Common Stock	50K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the vesting of restricted stock.
F2	Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
F3	2,778 and 47,222 restricted shares previously vested on September 13, 2021 and October 13, 2021, respectively, with the final 50,000 shares of restricted stock vesting on March 15, 2022.